Key result
TAVI proves feasible with acceptable outcomes in selected BAV stenosis, especially using new-generation devices.
Why the study?
Randomized trials comparing TAVI with surgery excluded bicuspid aortic valve patients, leaving the feasibility, safety, and outcomes of TAVI controversial in bicuspid aortic valve stenosis.
Does Transcatheter aortic valve replacement (TAVI) improve outcomes in patients with bicuspid aortic valve stenosis?
Does Transcatheter aortic valve replacement (TAVI) improve outcomes in patients with bicuspid aortic valve stenosis?
This review summarizes the feasibility, safety, and outcomes of TAVI in patients with bicuspid aortic valve stenosis, a population traditionally excluded from randomized clinical trials.
Supports TAVI in selected bicuspid cases; leaves open need for RCTs versus surgery.
As per the current scenario, role of Transcatheter aortic valve replacement (TAVI) is controversial in bicuspid aortic valve stenosis. All the randomized clinical trials comparing outcomes of TAVI with surgery till date, have excluded patients with bicuspid aortic valve. Some of the observational studies have reported outcomes of TAVI in bicuspid aortic valve stenosis patients who are not surgical candidate. The recent advances in TAVI and its expansion into intermediate groups, which includes younger age groups sparks a debate on the efficacy and safety of TAVI in Bicsuspid aortic valve (BAV). The purpose of the present article is to review the available literature regarding the feasibility, safety and outcomes of TAVI in bicuspid aortic valve stenosis.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2019) conducted a review in Bicuspid Aortic Valve Stenosis. Transcatheter aortic valve implantation (TAVI) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: